1. THU0223 The Novel CPLA2 Inhibitor AK106-001616 is a New Category of Anti-Inflammatory/Analgesic Drug Demonstrating Efficacy and Favorable Tolerability in the Treatment of Rheumatoid Arthritis. (23rd January 2014) Authors: Yamanishi, K.; Ellis, B.; Kudo, K.; Kayanoki, T.; Dews, I.; Ostor, A.; Wilson, A. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗